EX-23 2 dowinc-q3x9302022ex23.htm ANKURA CONSULTING GROUP, LLC'S CONSENT

| Ankura Consulting Group, LLC's Consent | EXHIBIT 23

Ankura Consulting Group, LLC (“Ankura”) hereby consents to the use of Ankura's name and the reference to Ankura's reports in this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company for the period ended September 30, 2022, and the incorporation by reference thereof in the following Registration Statements of Dow Inc. and The Dow Chemical Company:
DOW INC.

Form S-3: |
Nos. | 333-230668
| 333-232862
| 333-265556
Form S-8: |
Nos. | 333-220352-01
| 333-230680
| 333-230681
| 333-255472
| 333-255473

THE DOW CHEMICAL COMPANY

Form S-3: |
Nos. | 333-232862-01
| 333-265556-01
Form S-4: |
Nos. | 333-88443
| 333-234108
Form S-8: |
Nos. | 33-61795
| 333-40271
| 333-91027
| 333-103519
| 333-220352

Date: October 21, 2022

/s/ AMY BROCKMAN
Amy Brockman Senior Managing Director Ankura Consulting Group, LLC

70